NCT06481423

Brief Summary

The goal of this clinical trial is to explore whether cognitive behavioral intervention for insomnia(CBT-I) realized through audio, video, and articles on smartphone apps("ForSleep" developed by the investigators) can improve the sleep quality of insomnia patients. The main question it aims to answer is: Does CBT-I delivered via smartphone apps improve sleep quality evaluated by scales in patients with insomnia? Investigators will compare the treatment group receiving the CBT-I intervention via smartphone apps to a control group receiving relaxation training to see if there are significant improvements in sleep quality. Participants will be asked to: Use an app("ForSleep") designed for CBT-I to follow a structured therapy program. Complete daily sleep diaries and periodic scales to track their sleep quality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
358

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 20, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 1, 2024

Completed
Last Updated

June 4, 2025

Status Verified

May 1, 2025

Enrollment Period

4 months

First QC Date

June 20, 2024

Last Update Submit

May 30, 2025

Conditions

Keywords

Digital cognitive behavior therapy for insomniaChronic Insomnia

Outcome Measures

Primary Outcomes (1)

  • Pittsburgh Sleep Quality Index Scale(PSQI)

    A scale that evaluates sleep quality, the scale scores range from 0 to 21, and lower scores mean a better outcome

    baseline(before the intervention); intervention stage(every week during 3-week intervention); follow-up stage(every week during 2-week follow-up)

Secondary Outcomes (4)

  • Dysfunctional Beliefs and Attitudes about Sleep Scale(DBAS)

    baseline(before the intervention); intervention stage(every week during 3-week intervention); follow-up stage(every week during 2-week follow-up)

  • Sleep Hygiene Index Scale(SHI)

    baseline(before the intervention); intervention stage(every week during 3-week intervention); follow-up stage(every week during 2-week follow-up)

  • The Insomnia Severity Index Scale(ISI)

    baseline(before the intervention); intervention stage(every week during 3-week intervention); follow-up stage(every week during 2-week follow-up)

  • Epworth Sleepiness Scale(ESS)

    baseline(before the intervention); intervention stage(every week during 3-week intervention); follow-up stage(every week during 2-week follow-up)

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants receive digital cognitive behavioral intervention for insomnia(dCBT-I) via their smartphone, and can freely access relaxing music in the app

Behavioral: dCBT-IBehavioral: Relaxing music

Control Group

OTHER

Participants can only freely access relaxing music in the app. They don't have access to dCBT-I

Behavioral: Relaxing music

Interventions

dCBT-IBEHAVIORAL

A digital cognitive behavioral intervention course that addresses multiple aspects such as basic sleep knowledge, sleep hygiene, sleep behaviors, improving negative cognition, and improving emotions. The intervention is delivered through video, audio, and text formats.

Intervention Group
Relaxing musicBEHAVIORAL

Participants can freely listen relaxing music

Control GroupIntervention Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years old
  • Insomnia Severity Index Scale (ISI) score of 8\~21
  • Proficient in the use of smartphones
  • Chinese native speaker

You may not qualify if:

  • Those with other combined sleep problems, such as apnoea syndrome, restless leg syndrome, etc.
  • Women during pregnancy
  • risky jobs that require high concentration, such as working at heights, long-distance driving, etc.
  • previous or current diagnosis of severe neurological disorders such as epilepsy
  • previous or current diagnosis of mental illness such as depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder, etc.
  • history of drug or alcohol abuse
  • a significant negative risk of suicide
  • serious physical illness (e.g., cardiovascular, hepatic, renal, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University

Shanghai, Shanghai Municipality, 200433, China

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Shouyan Wang, PhD

    Fudan University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 20, 2024

First Posted

July 1, 2024

Study Start

May 1, 2023

Primary Completion

September 1, 2023

Study Completion

September 1, 2023

Last Updated

June 4, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Due to concerns regarding patient confidentiality and privacy, the investigators are unable to share the data from our study. The sensitive nature of the data includes personal health information that could potentially identify individual participants. Despite our best efforts to anonymize the data, the risk of re-identification remains. Additionally, the investigators are bound by ethical guidelines and institutional policies that require us to protect the privacy of our participants and maintain the confidentiality of their information. As such, the investigators must restrict access to the data to ensure compliance with these ethical and legal standards.

Locations